2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in

Schneider Children's VC

Status
ACTIVE
Global HQ
Petah Tikva, Israel
Countries of investment
  • Israel
Investment stages
  • Seed
  • Series A
Industries
  • Health Tech
  • Digital Health
  • MedTech
  • Medical Devices
  • Diagnostics
  • AI
  • Data Science
  • Life Sciences
About
Schneider Children's VC, or SCVC, is Israel's first venture fund dedicated exclusively to pediatric healthcare, set up by Schneider Children's Medical Center, part of Clalit Health Services, and run as a separate entity led by managing partner Ronen Gadot. Announced on 4 November 2026, the fund held an initial close and is targeting about $50M, with anchor investors including Schneider, Clalit, the Dor Group and Gadot himself. It began operating in February 2026 under an agreement with Clalit, has reviewed more than 170 companies and has completed its first three investments. Part of the fund's profits will be returned to Schneider for research and pediatric medicine.
Min check size
$500K
Max check size
$3M
Fund size
NPS

Investment Thesis

Schneider Children's VC invests in early-stage pediatric healthcare innovation, including technologies built specifically for children, AI that predicts treatment outcomes, non-invasive early diagnostics and the adaptation of longevity technologies to pediatric medicine. It writes cheques of $500K to $3M and evaluates companies, teams and products in a real clinical setting before investing, then helps with product development, business models and market entry. Its differentiator is privileged access to Schneider Children's Medical Center clinicians and Clalit Health Services data, plus planned collaborations with large technology companies in data and AI.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Managing partner Ronen Gadot was part of the founding team of Philips' global corporate venture arm, led its investments in Israel and drove its move into telemedicine through the investment, joint venture and IPO of SHL Telemedicine, later serving as CEO of its European subsidiary. He was the first investor in neurotechnology company Elminda, which he also led as CEO, and he sits on the Israel Innovation Authority investment committee. Earlier he worked at Applied Materials and flew with the Israeli Air Force aerobatic team.

Schneider Children's VC Contacts Information

Primary contact

Team

Ronen Gadot - Managing Partner

Portfolio

Cellergy Therapeutics

Noumena AI

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp